Paolo Manzoni, MD, PhD, has been for the last 12 years coordinator of the Italian Society of Neonatal Infectious Diseases, affiliated to the Italian Society of Neonatology in Italy.
He is a founding Board Member of the Excellence Research network on RSV named “Resvinet” since 2014 (www.resvinet.org)
Dr Manzoni earned his medical degree and specialization in Pediatrics from the University of Torino School of Medicine in 1989 and 1993, respectively, and conducted his residency in pediatric pulmonology and fellowship in infectious diseases and immunology at Azienda Ospedaliera OIRM ‒ S.Anna of Torino from 1991 to 1995, when he became part of the Faculty Staff of the Division of Neonatology and NICU at the S.Anna Hospital in the same Institution. From 2018, he moved to the positon of Head of the Maternal-Infant Medicine Department at the University of Torino Hospital “Degli Infermi” in Biella, and holds a position of Associate Professor of Pediatrics and Neonatology at the School of Medicine, University of Torino
Dr Manzoni has served on the Board of Directors for the Italian Society of Neonatology, of the European Association of Perinatal Medicine, and of the World Association of Perinatal Medicine.
He is an associate member of the American Society for Pediatric Research and the Italian Society of Neonatology and Pediatrics.
He is also an external consultant for Pediatrics and Neonatology for the Italian Drug Agency (AIFA) and for the Pediatric Committee at the EMA (Europe Medicine Agency) .
He is co-founder of the Charity and Scientific Foundation “Crescere insieme al Sant’Anna”.
Dr Manzoni’s primary research interests include pediatric and neonatal infectious diseases, fungal infections and prevention, human milk bioactive nutrients, RSV related diseases, retinopathy of prematurity, and neonatal nutrition.
He was the leading investigator of the first, multicenter clinical trial of prophylactic fluconazole in preterm neonates, as well as of the first international, multicenter clinical trial of probiotic and lactoferrin feeding in preterm neonates.
He was the leading investigator of a European project on fluconazole and ciprofloxacin in neonates funded by the European Union in accordance with the European Medicine Agency (EMA), acting as WP leader in the TINN consortium; he is also involved in several other EU-funded research consortiums devoted to the study of antimicrobial drugs for neonates (NeoMero, Neovanc, etc). He is the author of approximately 210 research articles published in peer-reviewed Italian and international medical journals, and Editor/Associate Editor of a number of peer-reviewed, leading international Journals.
